Review




Structured Review

Proteintech flt 1
Flt 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neutralizing+antibodies+against+sflt-1/VEGFR-1%2FFLT-1+Antibody/pmc10830578-89-10-13
Average 94 stars, based on 77 article reviews
flt 1 - by Bioz Stars, 2026-09
94/100 stars

Images

Related Articles

Incubation:

Article Title: Mantis shrimp saddle-mimetic amorphous calcium (zinc) phosphate/chitin scaffolds with superior mechanical properties and bioactivity for bone regeneration
Article Snippet: Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes (IPVH00010, Millipore, Burlington, MA, U.S.A). .. The membranes were incubated overnight at 4 ◦C with the following primary antibodies: Arnt/Hif1β (1:1000, 14105-1-AP, Proteintech), Fos (1:1000, 66590-1-Ig, Proteintech), Jun (1:1000, 24909-1-AP, Proteintech), Fgf2 (1:1000, 30333-1-AP, Proteintech), Vegfr1/Flt1 (1:1000, 13687-1-AP, Proteintech), Hif1α (1:2000, ab179483, Abcam), Vegfa (1:2000, ab214424, Abcam), and β-Actin (1:20000, 66009-1-Ig, Proteintech). ..

Article Title: Mantis shrimp saddle-mimetic amorphous calcium (zinc) phosphate/chitin scaffolds with superior mechanical properties and bioactivity for bone regeneration
Article Snippet: Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes (IPVH00010, Millipore, Burlington, MA, U.S.A). .. The membranes were incubated overnight at 4 °C with the following primary antibodies: Arnt/Hif1β (1:1000, 14105-1-AP, Proteintech), Fos (1:1000, 66590-1-Ig, Proteintech), Jun (1:1000, 24909-1-AP, Proteintech), Fgf2 (1:1000, 30333-1-AP, Proteintech), Vegfr1/Flt1 (1:1000, 13687-1-AP, Proteintech), Hif1α (1:2000, ab179483, Abcam), Vegfa (1:2000, ab214424, Abcam), and β-Actin (1:20000, 66009-1-Ig, Proteintech). ..

Article Title: Aging-dependent expression of vascular endothelial growth factor receptor-1 is associated with T-cell immune senescence in carotid atherosclerosis
Article Snippet: .. The sections underwent deparaffinization and blocking and were then exposed to the primary anti-Trail antibody (Proteintech, 27064-1-AP), vascular endothelial growth factor receptor-1 (anti-VEGFR1) (Proteintech, 13687-1-AP), or beta-galactosidase (Proteintech, 15518-1-AP) during incubation at 4°C overnight. ..

Acid Assay:

Article Title: E-cigarette exposure during pregnancy impairs uterine artery blood flow and feto-placental function.
Article Snippet: The popularity of electronic cigarettes (e-cigs) has risen in recent years, largely due to perceptions of reduced harm compared with traditional tobacco cigarettes.. E-cig use has spread into vulnerable populations such as adolescents and individuals of reproductive age, yet their safety during pregnancy remains poorly understood.. E-cigs differ from conventional cigarettes in composition, and their aerosolized components may uniquely affect the uterine environment and placental function.

Clinical Proteomics:

Article Title: E-cigarette exposure during pregnancy impairs uterine artery blood flow and feto-placental function.
Article Snippet: The popularity of electronic cigarettes (e-cigs) has risen in recent years, largely due to perceptions of reduced harm compared with traditional tobacco cigarettes.. E-cig use has spread into vulnerable populations such as adolescents and individuals of reproductive age, yet their safety during pregnancy remains poorly understood.. E-cigs differ from conventional cigarettes in composition, and their aerosolized components may uniquely affect the uterine environment and placental function.

Western Blot:

Article Title: Placental aberrant inflammation and spatial-specific lipid metabolism contribute to hypertensive disorder of pregnancy susceptibility in preeclampsia offspring.
Article Snippet: Epidemiological studies have demonstrated that daughters of preeclamptic mothers have an increased risk of hypertensive disorders of pregnancy (HDP), but the underlying mechanisms remain unclear.. To investigate the molecular changes underlying this HDP intergenerational transmission, we established an L-NAME-induced PE model in pregnant mice (F0) and examined female offspring (F1) during their pregnancies.. F1 females developed gestational hypertension in late pregnancy, accompanied by enlarged placental labyrinthine areas and elevated VGFR1 expression, despite normal circulating sFlt1 levels.

Blocking Assay:

Article Title: Plasticizer mixture exposure-induced preeclampsia pathogenesis: Integrated single-cell and bulk transcriptomics, network toxicology, and molecular docking insights.
Article Snippet: .. To expose antigens, the slides were immersed in boiling citrate buffer (10 mM, pH 6.0) for 20 min, followed by treatment with endogenous peroxidase blocker for 10 min. Block the slides with 10 % donkey serum at room temperature for 1 h, then incubate with primary antibodies BCL6 (mouse monoclonal IgG1, 1:100, Proteintech, 66340-1- Ig), VEGF-1/FLT-1 (rabbit polyclonal IgG, 1:100; Proteintech; 13687-1- AP), and inhibin α (rabbit monoclonal IgG, 1:100, Proteintech) in a humid chamber overnight at 4 ◦C. ..

Article Title: Aging-dependent expression of vascular endothelial growth factor receptor-1 is associated with T-cell immune senescence in carotid atherosclerosis
Article Snippet: .. The sections underwent deparaffinization and blocking and were then exposed to the primary anti-Trail antibody (Proteintech, 27064-1-AP), vascular endothelial growth factor receptor-1 (anti-VEGFR1) (Proteintech, 13687-1-AP), or beta-galactosidase (Proteintech, 15518-1-AP) during incubation at 4°C overnight. ..



Similar Products

90
R&D Systems neutralizing antibodies against sflt-1
Exogenous recombinant Wnt5a mediates SVFs vascular self-assembly. SVFs were treated with increasing concentrations of recombinant Wnt5a: (a and b) The effects of various concentrations of recombinant Wnt5a on neovascularization in Matrigel plugs. After stimulation with different concentrations of recombinant Wnt5a, the plugs were removed on day 14 after Matrigel injection for the visualization and quantification of angiogenesis. Representative photographs of plugs from groups of five animals are shown. Quantification of angiogenesis within the Matrigel plugs is shown for all conditions. (c and d) During stimulation with different concentrations of Wnt5a, the expression of the vascularization-stimulating factors MMP2, MMP9, VEGFR2, and <t>sFlt-1</t> in SVFs gradually increased. (e and f) At 4 weeks, the expression of Wnt5a and the vascular inhibitor sFlt-1 in the SVF-BAM group simultaneously increased. *p < 0.05; **p < 0.01; ***p < 0.005.
Neutralizing Antibodies Against Sflt 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neutralizing+antibodies+against+sflt-1/vegf+elisa+kit/pmc06886281-71-30-35
Average 90 stars, based on 1 article reviews
neutralizing antibodies against sflt-1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Exogenous recombinant Wnt5a mediates SVFs vascular self-assembly. SVFs were treated with increasing concentrations of recombinant Wnt5a: (a and b) The effects of various concentrations of recombinant Wnt5a on neovascularization in Matrigel plugs. After stimulation with different concentrations of recombinant Wnt5a, the plugs were removed on day 14 after Matrigel injection for the visualization and quantification of angiogenesis. Representative photographs of plugs from groups of five animals are shown. Quantification of angiogenesis within the Matrigel plugs is shown for all conditions. (c and d) During stimulation with different concentrations of Wnt5a, the expression of the vascularization-stimulating factors MMP2, MMP9, VEGFR2, and sFlt-1 in SVFs gradually increased. (e and f) At 4 weeks, the expression of Wnt5a and the vascular inhibitor sFlt-1 in the SVF-BAM group simultaneously increased. *p < 0.05; **p < 0.01; ***p < 0.005.

Journal: Journal of Tissue Engineering

Article Title: Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering

doi: 10.1177/2041731419891256

Figure Lengend Snippet: Exogenous recombinant Wnt5a mediates SVFs vascular self-assembly. SVFs were treated with increasing concentrations of recombinant Wnt5a: (a and b) The effects of various concentrations of recombinant Wnt5a on neovascularization in Matrigel plugs. After stimulation with different concentrations of recombinant Wnt5a, the plugs were removed on day 14 after Matrigel injection for the visualization and quantification of angiogenesis. Representative photographs of plugs from groups of five animals are shown. Quantification of angiogenesis within the Matrigel plugs is shown for all conditions. (c and d) During stimulation with different concentrations of Wnt5a, the expression of the vascularization-stimulating factors MMP2, MMP9, VEGFR2, and sFlt-1 in SVFs gradually increased. (e and f) At 4 weeks, the expression of Wnt5a and the vascular inhibitor sFlt-1 in the SVF-BAM group simultaneously increased. *p < 0.05; **p < 0.01; ***p < 0.005.

Article Snippet: Briefly, 2.5 × 10 5 SVFs were treated with five different concentrations of recombinant human Wnt5a (0, 10, 50, 100, and 200 ng/mL; R&D Systems, Minneapolis, MN, USA) or neutralizing antibodies against sFlt-1 (10 µg/mL; R&D Systems) premixed with Matrigel (1 mg/mL) and EGM-2, and injected subcutaneously into nude mice in both inguinal regions.

Techniques: Recombinant, Injection, Expressing

sFlt-1 suppresses the angiogenesis of SVFs: (a) Tube formation assays in SVFs treated with sFlt-1 neutralizing antibody, magnification ×40 and (b) Matrigel plug angiogenesis assay in SVFs treated with sFlt-1 neutralizing antibody. **p < 0.01.

Journal: Journal of Tissue Engineering

Article Title: Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering

doi: 10.1177/2041731419891256

Figure Lengend Snippet: sFlt-1 suppresses the angiogenesis of SVFs: (a) Tube formation assays in SVFs treated with sFlt-1 neutralizing antibody, magnification ×40 and (b) Matrigel plug angiogenesis assay in SVFs treated with sFlt-1 neutralizing antibody. **p < 0.01.

Article Snippet: Briefly, 2.5 × 10 5 SVFs were treated with five different concentrations of recombinant human Wnt5a (0, 10, 50, 100, and 200 ng/mL; R&D Systems, Minneapolis, MN, USA) or neutralizing antibodies against sFlt-1 (10 µg/mL; R&D Systems) premixed with Matrigel (1 mg/mL) and EGM-2, and injected subcutaneously into nude mice in both inguinal regions.

Techniques: Angiogenesis Assay